No fewer than five analysts have lifted their price target in the last week GoodRx Holdings Inc (NASDAQ:GDRX) stock is on the rise today, after an upgrade from RBC to "outperform" from "market perform," with a price-target hike to $10 from $8. This is just the latest in a string of bull notes for the stock, as GDRX has received five price-target hikes since a Raymond James upgrade a week ago. At last glance, GoodRx stock was up 2% at $7.35, earlier as high as $7.80. The equity has been trading choppily, wit ...

NEW YORK, May 23, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of GoodRx investors who were adversely affected by alleged securities fraud between September 23, 2022 and November 8, 2022. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/goodrx-lawsuit-submission ...

NEW YORK, May 21, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 8, 2022, both dates inclusive (the "Class Period"), of the important June 21, 2024 lead plaintiff deadline. WHAT TO DO NEXT: To join the GoodRx class action, go to https://rosenlegal.com/submit-form/? case_id=24355 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for info ...

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by tel ...

The class action concerns whether GoodRx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. NEW YORK, May 16, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged ...

It's also worth mentioning that both stocks have a bit of short squeeze potential. Short interest represents 10.8% of GDRX's available float, and 9.3% of BMBL's. Bumble stock isn't making any particularly outsized moves today, up 0.2% at $11.99. However, the stock is on a notable uptrend after its May 8 record low of $9.83. BMBL jumped broke above several short-term moving averages following this trough, including former pressure at the 60-day trendline. This week in Cheap Seats: Stocks Under $20 segment, w ...

RADNOR, Pa., May 15, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) ("GoodRx" or the "Company") on behalf of investors who purchased or acquired GoodRx common stock between September 23, 2020, and November 8, 2022, inclusive (the "Class Period"). This action, captioned Barsuli v. GoodRx Holdings, Inc., et al., Case No. Case 2:24-cv-03282- DDP-AJR was filed i ...

GoodRx Holdings, Inc. (GDRX) reported $197.88 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 7.6%. EPS of $0.08 for the same period compares to $0.07 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $196.2 million, representing a surprise of +0.86%. The company delivered an EPS surprise of -11.11%, with the consensus EPS estimate being $0.09.While investors closely watch year-over-year changes in headline numbers -- revenue and earni ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________ FORM 10-Q ________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-39549 ________________________ ...

GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.11%. A quarter ago, it was expected that this company would post earnings of $0.08 per share when it actually produced earnings of $0.08, delivering no surprise.Over the last four quarters, the company ha ...